Mitophagy has been reported to be involved in the inhibitory effect of Crenolanib, an FLT3 inhibitor, inducing Cer accumulation and subsequently promoting cell death in FLT3-mutated AML cells [198,199]. The gene discussed is FLT3; the disease is acute myeloid leukemia.